AI assistant
Ind-Swift Laboratories Ltd. — Major Shareholding Notification 2019
Apr 22, 2019
62552_rns_2019-04-22_b7db91fa-b5e4-4283-abab-6f1947e55f24.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Date: 1st April, 2019
The President, Corporate Relationship Department, BSE Limited, Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street. Mumbai 400 001
The Vice President, National Stock Exchange of India Limited, Exchange Plaza, 5th Floor, Plot No.C/2, G-Block, Bandra Kurla Complex, Bandra (E), Mumbai 400 051
BSE Scrip Code: 532305
NSE Symbol: INDSWFTLAB
SUB: DISCLOSURE UNDER CLAUSE 30(1) & (2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES & TAKEOVERS) REGULATIONS, 2011
Dear Sir,
Pursuant to Clause 30(1) and (2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, please find enclosed herewith a duly filled disclosure in the prescribed format regarding details of shareholding of promoter(s)/ promoters group as on 31st March, 2019 in Ind-Swift Laboratories Limited for your information and record.
You are requested to kindly take a record of the same.
Thanking you, For and on behalf of Promoter & Promoters Group
nauteatter h
(Navrattan Munial)
Encl.: As above
$CC:$ Sh. Pardeep Verma, AVP-Corporate Affairs & Company Secretary, Ind-Swift Laboratories Limited for information & necessary action.
Part-A - Details of Shareholding
| 1. | Name of the Target Company (TC) | IND-SWIFT LABORATORIES LIMITED | ||
|---|---|---|---|---|
| $\overline{2}$ | Name of Stock Exchanges where shares ofreporting/target company are listed | National Stock Exchange of India Ltd.BSE Ltd. | ||
| 3 | Particulars of the Shareholder(s)A. Name of Person(s) together with Persons Actingin Concert (PAC) whose total holding (including thatin the form of shares, warrants, convertible securitiesB. Name(s) of promoter(s) member of the promotergroup and PAC with him. | 1Ind-Swift Limited23Mr. N.R. Munjal4Mr. Rishav Mehta56Mrs. Neera Mehta7Mr. S.R. Mehta8Dr. Gopal Munjal9Dr. V.R. Mehta10Mrs. Sunita Jain11Mrs. Neeta Munjal12Mrs. Nidhi Munjal13Mrs. Ravi Mehta1415Ms. Ishav Mehta16Ms. Bhanvi Mehta17Ms. Divya Munjal | Promoter & Promoter GroupEssix Biosciences LimitedMr. Himanshu JainMrs. Meenakshi Mehta | |
| 18Mr. Annie Mehta19Mr. Sahil MunjalNo. of Shares | % w.r.t. total | % of total diluted | ||
| 4 | share/ votingcapital | share/voting capital ofTC('') | ||
| Particular of shareholding of Person(s) mentionedat (3) above as of 31st March, 2019 | ||||
| As of March 31st of the year, holding of:a)Shares | ||||
| 1 | Ind-Swift Limited | 9499720 | 19.97 | 19.97 |
| 2 | Essix Biosciences Limited | 12827787 | 26.97 | 26.97 |
| 3 | Mr. N.R. Munjal | 920724 | 1.94 | 1.94 |
| 4 | Mr. Rishav Mehta | 454545 | 0.96 | 0.96 |
| 5 | Mr. Himanshu Jain | 406961 | 0.86 | 0.86 |
| 6 | Mrs. Neera Mehta | 249000 | 0.52 | 0.52 |
| 78 | Mr. S.R. Mehta | 233600 | 0.49 | 0.49 |
| 9 | Dr. Gopal MunjalDr. V.R. Mehta | 60900 | 0.13 | 0.13 |
| 10 | Mrs. Sunita Jain | 52900 | 0.11 | 0.11 |
| 11 | Mrs. Neeta Munjal | 46100 | 0.10 | 0.10 |
| 12 | Mrs. Nidhi Munjal | 12000 | 0.03 | 0.03 |
| 13 | Mrs. Ravi Mehta | 12000 | 0.03 | 0.03 |
| 14 | 12000 | 0.03 | 0.03 | |
| 15 | Mrs. Meenakshi MehtaMs. Ishav Mehta | 12000 | 0.03 | 0.03 |
| 16 | Ms. Bhanvi Mehta | 3000 | 0.01 | 0.01 |
| 17 | Ms. Divya Munjal | 3000 | 0.01 | 0.01 |
| 18 | Mr. Annie Mehta | 3000 | 0.01 | 0.01 |
| 19 | Mr. Sahil Munjal | 27802000 | 0.01 | 0.01 |
| Total: | 24814017 | 0.00 | 0.00 | |
| b) Voting rights (otherwise than by shares) | NII | 52.16 | 52.16 | |
| c) Warrants | Nil | NilNil | Nil | |
| d) Convertible Securities | Nil | Nil | Nil | |
| e) Any other instrument that would entitle the | Nil | |||
| holder to receive shares in the TC. | Nil | Nil | Nil |
$($
$\mathbf{I}$
Diluted share/voting captial means the total number of shares in the TC assuming full conversion of the outstandingcongertible securities/warrants into equity shares of the TC
FOR AND ON BEHALF OF PROMOTER AND PROMOTER'S GROUP
$\sqrt{\alpha/2}$ $\mu^{\sharp}.$
(NAVRATTAN MUNJAL)
Place: Chandigarh Date: 1st April, 2019
| Name of the Target Company (TC) | IND-SWIFT LABORATORIES LIMITED | |
|---|---|---|
| Name(s) of the person and personsacting in concert (PAC) with theperson) | Whether the person belongsto Promoter/ Promoter Group | |
| Ind-Swift Limited | Yes | |
| Essix Biosciences Limited | Yes | |
| Mr. N.R. Munjal | Yes | |
| Mr. Rishav Mehta | Yes | |
| Mr. Himanshu Jain | Yes | |
| Mrs. Neera Mehta | Yes | |
| Mr. S.R. Mehta | Yes | |
| Dr. Gopal Munjal | Yes | |
| Dr. V.R. Mehta | Yes | |
| Mrs. Sunita Jain | Yes | |
| Mrs. Neeta Munjal | Yes | |
| Mrs. Nidhi Munjal | Yes | |
| Mrs. Ravi Mehta | Yes | |
| Mrs. Meenakshi Mehta | Yes | |
| Ms. Ishav Mehta | Yes | |
| Ms. Bhanvi Mehta | Yes | |
| Ms. Divya Munjal | Yes | |
| Mr. Annie Mehta | Yes | |
| Mr. Sahil Munjal | Yes |
FOR AND ON BEHALF OF PROMOTER AND PROMOTER'S GROUP
$\mathbb{M}$
(NAVRATTAN MUNJAL)
Place: ChandigarhDate: 1st April, 2019
** Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.